Edition:
India

Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK)

2196.HK on Hong Kong Stock

26.40HKD
19 Oct 2018
Change (% chg)

HK$0.70 (+2.72%)
Prev Close
HK$25.70
Open
HK$25.60
Day's High
HK$27.10
Day's Low
HK$25.35
Volume
3,247,549
Avg. Vol
4,440,112
52-wk High
HK$54.40
52-wk Low
HK$25.35

Latest Key Developments (Source: Significant Developments)

Diamedica Therapeutics And Ahon Pharma Announce Signing Of License Agreement For Dm199 In China
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - DiaMedica Therapeutics Inc ::DIAMEDICA THERAPEUTICS AND AHON PHARMA, A FOSUN PHARMA PORTFOLIO COMPANY, ANNOUNCES SIGNING OF LICENSE AGREEMENT FOR DM199 IN CHINA FOR ACUTE ISCHEMIC STROKE.DIAMEDICA -AGREEMENT ALLOWS AHON TO HAVE EXCLUSIVE RIGHTS TO DEVELOP & COMMERCIALIZE DM199 IN MAINLAND CHINA, TAIWAN, HONG KONG S.A.R. AND MACAU S.A.R.DIAMEDICA THERAPEUTICS - UNDER TERMS OF AGREEMENT, CO IS ENTITLED TO RECEIVE AN UPFRONT PAYMENT OF $5 MILLION, UPON CLEARANCE TO INITIATE CLINICAL TRIAL IN CHINA.DIAMEDICA -HAS POTENTIAL TO RECEIVE $27.5 MILLION IN DEVELOPMENT, SALES RELATED MILESTONES,HIGH SINGLE & LOW DOUBLE-DIGIT ROYALTIES ON NET SALES OF DM199.  Full Article

Shanghai Fosun Pharmaceutical Group Approves Proposed Overseas Listing Of Shanghai Henlius Biotech, Inc
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::BOARD APPROVED PROPOSED OVERSEAS LISTING OF SHANGHAI HENLIUS BIOTECH, INC ON STOCK EXCHANGE OF HONG KONG LTD.  Full Article

Shanghai Fosun Pharma Group Says Conclusive Opinion Of Chongqing FDA's Unannounced Inspection Yet To Be Finalised
Friday, 31 Aug 2018 

Aug 31 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD - CLARIFIES ON RECENT MEDIA REPORTS.SHANGHAI FOSUN PHARMACEUTICAL GROUP CO - ON AUG 23, CHONGQING FDA MADE UNANNOUNCED INSPECTION AT CHONGQING RESEARCH INSTITUTE.SHANGHAI FOSUN PHARMACEUTICAL GROUP CO - CONCLUSIVE OPINION OF CHONGQING FDA'S UNANNOUNCED INSPECTION YET TO BE FINALISED.SHANGHAI FOSUN PHARMACEUTICAL-CHONGQING FDA GOT LETTER ON BREACH OF DRUG ADMINSTARTION LAW BY PHARMA CO OF CHONGQING PHARMACEUTICAL RESEARCH INSTITUTE.  Full Article

Shanghai Fosun Pharma Clarifies Media Reports, Says Unit Checked By Medicine Regulator
Thursday, 30 Aug 2018 

Aug 31 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK ::SAYS MEDICINE REGULATOR HAS CHECKED ITS CHONGQING UNIT BUT HAS NOT HAD CONCLUSION YET, RESPONDING TO MEDIA REPORTS THAT ITS UNIT VIOLATED MEDICINE REGULATIONS.SAYS IT WILL MONITOR DEVELOPMENTS CLOSELY AND DISCLOSE RELATED INFORMATION ON TIME.  Full Article

Shanghai Fosun Pharmaceutical Group to pay cash dividend of 0.38 yuan per share on Aug. 3
Friday, 27 Jul 2018 

July 27 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says it will pay a cash dividend of 0.38 yuan per share (before tax) for 2017 to shareholders of record on Aug. 2.The company's shares will be traded ex-right and ex-dividend on Aug. 3 and the dividend will be paid on Aug. 3 .  Full Article

Shanghai Fosun Pharmaceutical Group Announces Placing Of H Shares Under General Mandate
Thursday, 19 Jul 2018 

July 19 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::ANNOUNCES PLACING OF H SHARES UNDER GENERAL MANDATE.NET PROCEEDS OF PLACING WILL BE ABOUT HK$2,578.07 MILLION.PLACING SHARES COMPRISE 68 MILLION H SHARES TO BE ALLOTTED AND ISSUED BY CO.PLACING SHARES AT PLACING PRICE OF HK$38.20 PER H SHARE.  Full Article

Shanghai Fosun Pharmaceutical's Unit To Invest About $106 Mln In Butterfly Network Inc
Friday, 13 Jul 2018 

July 13 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS UNIT TO INVEST ABOUT $106 MILLION IN BUTTERFLY NETWORK INC.  Full Article

Shanghai Fosun Pharmaceutical Group unit receives approval for drug clinical trial
Thursday, 12 Jul 2018 

July 12(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says its Jiangsu-based biomedical unit received approval for drug clinical trial for a kind of tablet, from China Food and Drug Administration.  Full Article

Shanghai Fosun Pharmaceutical Group Says Fosun High Tech Acquired 2 Mln H Shares Of Co
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::FOSUN HIGH TECH ACQUIRED 2 MILLION H SHARES OF CO AT AVERAGE PURCHASE PRICE OF HK$40.15 PER H SHARE.DEAL FOR TOTAL PURCHASE PRICE OF RMB68.23 MILLION.  Full Article

Shanghai Fosun Pharmaceutical Group unit receives GMP certificate
Wednesday, 27 Jun 2018 

June 27(Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>:Says unit received goods manufacture practice (GMP) certificate from Sichuan Food and Drug Administration.Certificate issued to powder-injection manufactured by the unit and the valid period is until May 20, 2023.  Full Article